Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease
American Journal of Physiology-Cell Physiology · 2024
DOI: 10.1152/ajpcell.00386.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Tomasz W Kaminski und 13 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States. Hauptthemen laut MEDLINE: Antigens, Differentiation, Myelomonocytic, Anemia, Sickle Cell, Antigens, CD, Hemolysis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI).
Abstract (Originalsprache)
Sickle cell disease (SCD)-associated chronic hemolysis promotes oxidative stress, inflammation, and thrombosis leading to organ damage, including liver damage. Hemoglobin scavenger receptor CD163 plays a protective role in SCD by scavenging both hemoglobin-haptoglobin complexes and cell-free hemoglobin. A limited number of studies in the past have shown a positive correlation of CD163 expression with poor disease outcomes in patients with SCD. However, the role and regulation of CD163 in SCD-related hepatobiliary injury have not been fully elucidated yet. Here we show that chronic liver injury in SCD patients is associated with elevated levels of hepatic membrane-bound CD163. Hemolysis and increase in hepatic heme, hemoglobin, and iron levels elevate CD163 expression in the SCD mouse liver. Mechanistically we show that heme oxygenase-1 (HO-1) positively regulates membrane-bound CD163 expression independent of nuclear factor erythroid 2-related factor 2 (NRF2) signaling in SCD liver. We further demonstrate that the interaction between CD163 and HO-1 is not dependent on CD163-hemoglobin binding. These findings indicate that CD163 is a potential biomarker of SCD-associated hepatobiliary injury. Understanding the role of HO-1 in membrane-bound CD163 regulation may help identify novel therapeutic targets for hemolysis-induced chronic liver injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States.
- Transfusion Medicine, Vascular Biology and Cell Therapy Program, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States.
- Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.
- Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
- Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.
ORCID-Profile: Tomasz W Kaminski, Jesús Tejero, Enrico M Novelli, Tirthadipa Pradhan-Sundd
Förderung
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NHLBI NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- American Society of Hematology (ASH)
- NIDDK NIH HHS
- American Heart Association (AHA)
- Versiti
Zitieren
APA
Kaminski, T. W., Sivanantham, A., Mozhenkova, A., Smith, A., Ungalara, R., Dubey, R. K., Shrestha, B., Hanway, C., Katoch, O., Tejero, J., Sundd, P., Novelli, E. M., Kato, G. J., & Pradhan-Sundd, T. (2024). Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00386.2023
Vancouver
Kaminski TW, Sivanantham A, Mozhenkova A, Smith A, Ungalara R, Dubey RK, et al. Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00386.2023
BibTeX
@article{Kaminski2024,
author = {Kaminski, Tomasz W and Sivanantham, Ayyanar and Mozhenkova, Anna and Smith, Ashley and Ungalara, Ramakrishna and Dubey, Rikesh K and Shrestha, Bibhav and Hanway, Corrine and Katoch, Omika and Tejero, Jesús and Sundd, Prithu and Novelli, Enrico M and Kato, Gregory J and Pradhan-Sundd, Tirthadipa},
title = {Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
doi = {10.1152/ajpcell.00386.2023}
}
EUVIMED